Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: Nov. 11, 2025

Reporting date: Nov. 13, 2025

Average share price: -10.136708860759494

Sold 3792.0 shares for 38438.4